Amendment No. 1 to Master Services Agreement, effective February 12, 2025, between Cingulate Therapeutics LLC and Societal CDMO, Inc. (DBA Bend Bioscience)

Contract Categories: Business Operations - Services Agreements
EX-10.3 3 ex10-3.htm

 

Exhibit 10.3